Takeda Pharmaceutical Company Limited (TAK)

NYSE: TAK · Real-Time Price · USD

19.45

+0.44 (2.31%)

At close: Oct 15, 2026, 4:00 PM EDT

19.47

+0.02 (0.10%)

After-hours: Oct 15, 2026, 7:45 PM EDT

Takeda Pharmaceutical Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct '26 Oct 15, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	62,433	56,275	45,074	43,399	50,869	44,662
Market Cap Growth	45.66%	24.85%	3.86%	-14.68%	13.90%	-20.71%
Enterprise Value	94,536	86,263	78,050	75,918	81,755	74,563
Last Close Price	19.45	18.52	14.42	12.98	14.90	12.48

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct '26 Oct 15, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
PE Ratio	-	-	62.54	45.57	21.33	23.57
PS Ratio	2.20	1.99	1.47	1.54	1.68	1.52
PB Ratio	1.34	1.20	0.97	0.90	1.06	0.95
P/FCF Ratio	12.78	10.34	7.88	12.14	8.08	5.42
P/OCF Ratio	10.34	8.59	6.39	9.16	6.92	4.83

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct '26 Oct 15, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
EV/Sales Ratio	3.33	3.04	2.55	2.69	2.70	2.54
EV/EBITDA Ratio	12.30	11.10	9.48	9.33	8.46	7.65
EV/EBIT Ratio	24.03	22.57	20.76	22.85	17.54	15.09
EV/FCF Ratio	19.36	15.85	13.65	21.23	12.99	9.06

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct '26 Oct 15, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Debt / Equity Ratio	0.73	0.74	0.73	0.75	0.77	0.85
Debt / EBITDA Ratio	4.26	4.26	3.96	4.44	3.79	4.07
Debt / FCF Ratio	7.17	6.33	5.94	10.10	5.81	4.81
Net Debt / Equity Ratio	0.67	0.66	0.68	0.69	0.68	0.70
Net Debt / EBITDA Ratio	4.06	3.95	3.81	4.07	3.37	3.35
Net Debt / FCF Ratio	6.58	5.64	5.49	9.25	5.17	3.96
Asset Turnover	0.31	0.30	0.31	0.29	0.30	0.27
Inventory Turnover	1.22	1.24	1.30	1.30	1.36	1.40
Quick Ratio	0.51	0.52	0.44	0.50	0.49	0.73
Current Ratio	1.14	1.09	1.01	1.11	0.97	1.21
Return on Equity (ROE)	-2.26%	-2.12%	1.52%	2.12%	5.27%	4.24%
Return on Assets (ROA)	2.69%	2.55%	2.40%	2.16%	2.85%	2.88%
Return on Invested Capital (ROIC)	5.13%	5.08%	2.91%	4.38%	5.15%	4.82%
Return on Capital Employed (ROCE)	5.00%	4.80%	4.80%	3.90%	5.40%	5.40%

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct '26 Oct 15, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Earnings Yield	-1.61%	-1.70%	1.60%	2.20%	4.69%	4.24%
FCF Yield	7.82%	9.67%	12.69%	8.24%	12.37%	18.44%
Dividend Yield	2.53%	3.53%	4.57%	4.49%	4.14%	5.15%
Payout Ratio	-	-	280.28%	199.34%	88.14%	123.30%
Buyback Yield / Dilution	1.64%	1.88%	-1.58%	-0.67%	0.46%	-0.23%
Total Shareholder Return	4.17%	5.42%	2.99%	3.83%	4.60%	4.92%

SEC Filings: 10-K · 10-Q